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Abstract
Background: Negative pressure wound therapy (NPWT) is widely applied, although the evidence base is weak.
Previous reviews on medical interventions have shown that conclusions based on published data alone may no
longer hold after consideration of unpublished data. The main objective of this study was to identify unpublished
randomised controlled trials (RCTs) on NPWT within the framework of a systematic review.
Methods: RCTs comparing NPWT with conventional wound therapy were identified using MEDLINE, EMBASE,
CINAHL and The Cochrane Library. Every database was searched from inception to May 2005. The search was
updated in December 2006. Reference lists of original articles and systematic reviews, as well as congress
proceedings and online trial registers, were screened for clues to unpublished RCTs. Manufacturers of NPWT
devices and authors of conference abstracts were contacted and asked to provide study information. Trials were
considered nonrandomised if concealment of allocation to treatment groups was classified as "inadequate". The
study status was classified as "completed", "discontinued", "ongoing" or "unclear". The publication status of
completed or discontinued RCTs was classified as "published" if a full-text paper on final study results (completed
trials) or interim results (discontinued trials) was available, and "unpublished" if this was not the case. The type of
sponsorship was also noted for all trials.
Results: A total of 28 RCTs referring to at least 2755 planned or analysed patients met the inclusion criteria: 13
RCTs had been completed, 6 had been discontinued, 6 were ongoing, and the status of 3 RCTs was unclear. Full-
text papers were available on 30% of patients in the 19 completed or discontinued RCTs (495 analysed patients
in 10 published RCTs vs. 1154 planned patients in 9 unpublished RCTs). Most information about conference
abstracts and unpublished study information referring to trials that were unpublished at the time these documents
were generated was obtained from the manufacturer Kinetic Concepts Inc. (KCI) (19 RCTs), followed by The
Cochrane Library (18) and a systematic review (15). We were able to obtain some information on the methods
of unpublished RCTs, but results data were either not available or requests for results data were not answered;
the results of unpublished RCTs could therefore not be considered in the review. One manufacturer, KCI,
sponsored the majority of RCTs (19/28; 68%). The sponsorship of the remaining trials was unclear.
Conclusion: Multi-source comprehensive searches identify unpublished RCTs. However, lack of access to
unpublished study results data raises doubts about the completeness of the evidence base on NPWT.
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Background
Conservative estimates report that about 1% of the popu-
lation in Western countries is affected by chronic wounds
[1], with a much higher prevalence rate in inpatient and
nursing facilities [2]. Besides presenting a significant risk
factor for complications such as infection and amputa-
tion, chronic wounds also lead to marked impairment of
patients' quality of life [3,4].
Negative pressure wound therapy (NPWT) consists of an
open-cell foam dressing covered with an adhesive drape.
The dressing is connected to a vacuum pump that creates
and maintains a subatmospheric pressure [5]. The most
commonly used NPWT device is the Vacuum Assisted Clo-
sure (V.A.C.®) device.
The Federal Joint Committee (Gemeinsame Bundesauss-
chuss), the decision-making body of the self-administra-
tion of the German health care service, commissioned the
Institute for Quality and Efficiency in Health Care (Institut
für Qualität und Wirtschaftlichkeit im Gesundheitswesen,
IQWiG) to conduct a systematic review on the efficacy and
safety of NPWT versus conventional wound therapy in
patients with acute or chronic wounds. The full review was
published in German in March 2006, and an English-lan-
guage article has recently been published [6,7]. An update
of the systematic review, a rapid report, was published in
German in January 2007 [8].
Although NPWT is widely applied, particularly for chronic
wounds, at the time of the review only a few relevant ran-
domised controlled trials (RCTs) were available; these
were, moreover, of poor quality [9]. Previous reviews on
NPWT have not provided clear evidence of the superiority
of NPWT over conventional wound therapy. For example,
a review published by the Canadian Medical Advisory Sec-
retariat in 2006 concluded that "Based on the evidence to
date, the clinical effectiveness of NPWT to heal wounds is
unclear" [10].
Previous reviews on medical interventions have shown
that conclusions on efficacy and safety based on pub-
lished data alone may no longer hold after consideration
of unpublished data, which may reverse favourable risk-
benefit profiles and attenuate treatment effects of an
apparently superior intervention [11-13]. Within the
framework of the systematic review on NPWT, our main
objective was therefore not only to identify published, but
also unpublished completed or discontinued RCTs in
order to gain as complete an overview as possible of the
evidence on NPWT. Further aims were to locate ongoing
RCTs for potential consideration in future updates, and to
determine the type of sponsorship of all eligible trials.
Methods
The literature search comprised a total of 7 steps. Table 1
shows an overview of the sources used.
We searched 4 bibliographic databases (MEDLINE,
EMBASE, CINAHL, and The Cochrane Library) for RCTs
on NPWT versus conventional wound therapy in patients
with acute or chronic wounds. All databases were
searched from inception to May 2005. The search was
updated in December 2006 within the framework of the
preparation of the rapid report on NPWT [8]. The search
strategy in MEDLINE (Table 2) was applied according to
the Cochrane Highly Sensitive Search Strategy described
in the Cochrane Handbook for Systematic Reviews of
Interventions [14], and tailored to the requirements of
each database. Other search strategies are available upon
request.
We then screened online trial registers (Table 1) and the
US Food and Drug Administration website, and contacted
German authorities, requesting information on all availa-
ble RCTs on NPWT. Prior to the start of the review, the
Federal Joint Committee had asked experts to provide rel-
evant literature; these citations were also obtained by
IQWiG as part of the commission. Moreover, the refer-
ence lists of retrieved original articles and systematic
reviews, as well as congress proceedings, were hand-
searched.
Two manufacturers of NPWT devices were identified:
Kinetic Concepts Inc. (KCI, San Antonio, Texas, USA)
markets the V.A.C.® device, and BlueSky Medical Group
Inc. (BSM, Carlsbad, California, USA) markets the Versa-
tile 1 Wound Vacuum System®. Both were asked to pro-
vide information on the study status and publication
status of sponsored trials, as well as on methods and
results. Finally, we contacted the authors of conference
abstracts by e-mail and by post. All contact details of the
relevant institutions were checked beforehand on the cor-
responding websites. Manufacturers and authors were
informed that IQWiG does not accept "commercial in
confidence" data and publishes all data contributing to a
systematic review [15].
All languages were included, as long as a title was availa-
ble in English. If the title indicated a potential relevance of
the study, the corresponding article was obtained and
translated. Only RCTs comparing NPWT versus conven-
tional therapy were eligible. Trials were considered non-
randomised if concealment of allocation to treatment
groups was classified as "inadequate" [16]. The interven-
tion was classified as NPWT if a medical device system
identical or comparable to the V.A.C.® Therapy System was
used.BMC Medical Research Methodology 2008, 8:4 http://www.biomedcentral.com/1471-2288/8/4
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Results of trials that were not available as full-text publica-
tions were only considered in the review if detailed data
Table 1: Literature sources and search steps*
Category Sources
Step 1
Bibliographic databases† MEDLINE: Includes PubMed and Clinical Queries.
EMBASE
The Cochrane Library. These databases were searched:
Cochrane Database of Systematic Reviews (CDSR; Cochrane Reviews)
Database of Abstracts of Reviews of Effects (DARE; Other Reviews)
Cochrane Central Register of Controlled Trials (CENTRAL; Clinical Trials)
Health Technology Assessment Database (HTA; Technology Assessments)
NHS Economic Evaluation Database (NHSEED; Economic Evaluations)
CINAHL
Step 2
Online trial registers ClinicalTrials.gov
National Research Register (NRR)
Step 3
Authorities German Federal Joint Committee (references cited by experts in 2003)
United States Federal Drug Administration (FDA) (online search)
German Federal Institute for Drugs and Medical Devices (direct enquiry by e-mail and phone)
Step 4
Systematic reviews‡ Ontario Health Technology Advisory Committee 2006 (OHTAC)
Pham 2006, Australian Safety and Efficacy Register of New Interventional Procedures – 
Surgical (ASERNIP-S)
Costa 2005, McGill University Health Centre Technology Assessment Unit (MUHC)
Samson 2004, United States Agency for Healthcare Research and Quality (AHRQ)
Higgins 2003, Centre for Clinical Effectiveness (CCE)
Fisher 2003, Canadian Coordinating Office of Health Technology Assessment (CCOHTA)
Evans 2001, Cochrane database of systematic reviews (CDSR)
Step 5
Congress proceedings V.A.C.® Wundtherapie, 10 Jahre V.A.C., Drei-Länder-Kongress [V.A.C. Wound Therapy, 10 
Years of V.A.C., Three-Country Conference], Graz, Austria; 2005.
Symposium on Advanced Wound Care, San Diego, California, USA; 2005.
Second World Union of Wound Healing Societies Meeting, Paris, France; 2004.
V.A.C.® Wundtherapie, Drei-Länder-Kongress [V.A.C. Wound Therapy, Three-Country 
Conference], Mainz, Germany; 2004.
First international topical negative pressure (TNP) therapy focus group meeting in London, 
UK, December 2003. Proceedings. Edited by: Banwell P, Teot L. Supported by the European 
Tissue Repair Society. Faringdon, UK: TXP Communications; 2004.
Vacuum Assisted Closure (V.A.C.®), Salzburg, Austria; 2003.
Eleventh Annual Meeting and Educational Symposium, Wound Healing Society, Albuquerque, 
New Mexico, USA; 2001.
Step 6
Manufacturers (direct enquiries by e-mail and post) Kinetic Concepts, Inc., San Antonio, Texas, USA.
BlueSky Medical Group, Inc., Carlsbad, California, USA
Step 7
Authors (direct enquiries by e-mail and post) Adams; Armstrong; Bayer; Foo; Fryer; Greer; Gupta; Heath; Lantis; McCarthy J; McCarthy M; 
Molnar; Niezgoda; Orgill; Payne; Stannard (3 RCTs); Vuerstaek; Walker
* Other sources available on request.
† Search executed in May 2005 and updated in December 2006.
‡ Hayes 2003 [71] was not publicly available and therefore not considered. OHTAC 2004 [72] and Pham 2003 [73] were not considered because 
updated versions are available.BMC Medical Research Methodology 2008, 8:4 http://www.biomedcentral.com/1471-2288/8/4
Page 4 of 16
(page number not for citation purposes)
Table 2: Search strategy applied in MEDLINE
No. Search terms
1 amputation$.ti,ab.
2 exp AMPUTATION/
3 exp AMPUTATION TRAUMATIC/
4 burn$.ti,ab.
5e x p  B U R N S /
6 decubit$.ti,ab.
7 deglov$.ti,ab.
8 diabet$.ti,ab.
9 exp DIABETES MELLITUS/
10 electric$ injur$.ti,ab.
11 frostbit$.tw.
12 exp FROSTBITE/
13 laceration$.ti,ab.
14 exp LACERATIONS/
15 open-abdom$.ti,ab.
16 exp ABDOMINAL WALL/su
17 plastic-surg$.ti,ab.
18 exp SURGERY, PLASTIC/
19 reconstruct$-surg$.ti,ab.
20 exp RECONSTRUCTIVE SURGICAL PROCEDURES/
21 skin-graft$.ti,ab.
22 skin-transplant$.ti,ab.
23 exp SKIN TRANSPLANTATION/
24 surg$ flap.ti,ab.
25 exp SURGICAL FLAPS/
26 thermal injur$.ti,ab.
27 exp ELECTRIC INJURIES/
28 ulcer$.ti,ab.
29 ul#us$.ti,ab.
30 exp SKIN ULCER/
31 exp SOFT TISSUE INFECTIONS/
32 exp ULCER/
33 wound$.ti,ab.
34 exp WOUND INFECTION/
35 exp WOUND HEALING/
36 wound dehiscence.ti,ab.
37 exp SURGICAL WOUND DEHISCENCE/
38 "mini-v.a.c.$".ti,ab.
39 negative-pressur$.ti,ab.
40 subatmospheric-pressur$.ti,ab.
41 sub-atmospheric-pressur$.ti,ab.
42 $suction$.ti,ab.
43 exp SUCTION/
44 vacuum$.ti,ab.
45 exp VACUUM/
46 (clin$ adj25 trial$).ti,ab.
47 clinical trial.pt.
48 exp CLINICAL TRIALS/
49 (control$ or prospectiv$ or volunteer$).ti,ab.
50 controlled clinical trial.pt.
51 COMPARATIVE STUDY.sh.
52 DOUBLE BLIND METHOD.sh.
53 exp EVALUATION STUDIES/
54 FOLLOW-UP STUDIES.sh.
55 placebo$.ti,ab.
56 PLACEBOS.sh.
57 PROSPECTIVE STUDIES.sh.
58 random$.ti,ab.
59 randomized controlled trial.pt.BMC Medical Research Methodology 2008, 8:4 http://www.biomedcentral.com/1471-2288/8/4
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were available (e.g. from a clinical study report or a man-
uscript in press). Results data from conference abstracts
were not considered.
All steps of the literature screening were performed by two
reviewers independently of one another. Any disagree-
ments were resolved by discussion. The titles and abstracts
of the retrieved documents were screened to exclude cita-
tions that were clearly irrelevant. The full texts of the
remaining potentially relevant articles were then screened
to identify RCTs that fulfilled the inclusion criteria stated
above.
With the help of the information obtained, the study sta-
tus of the RCTs identified was classified as "completed",
"discontinued", "ongoing" or "unclear". The terminology
used in the literature to classify unpublished data or so-
called "grey literature" is inconsistent [12]. We classified
the publication status of completed or discontinued trials
as "published" if a full-text paper on final study results
(completed trials) or interim results (discontinued trials)
was identified in the literature search, and "unpublished"
if this was not the case. In addition, for ongoing trials it
was indicated whether interim results were available or
not. The type of sponsorship was also noted for all trials.
Only a summary of results on the quality assessment and
outcomes of the RCTs included in the IQWiG systematic
review and rapid report is presented here, as the main
focus of this paper was to identify unpublished RCTs.
Results
An overview of the search results is presented in Table 3.
Detailed information on identified published and unpub-
lished RCTs, as well as on the RCTs included in the sys-
tematic review and rapid report, is presented in Table 4.
Search results
Of 2675 potentially relevant publications, 317 full-text
papers were obtained for further assessment. Of these,
289 were excluded as not relevant (Figure 1).
A total of 28 RCTs on NPWT referring to at least 2755
planned or analysed patients were identified: 13 RCTs
(801 patients; 29%) had been completed [17-29], 6 RCTs
(848 patients; 31%) had been discontinued [30-35], 6
60 RANDOM ALLOCATION.sh.
61 RANDOMIZED CONTROLLED TRIALS.sh.
62 RESEARCH DESIGN.sh.
63 SINGLE BLIND METHOD.sh.
64 ((singl$ or doubl$ or trebl$ or tripl$) adj25 (blind$ or mask$)).ti,ab.
65 or/1–37
66 or/38–45
67 or/46–65
68 and/66–68
Note: We have amended or deleted 2 terms contained in the original strategy. The first term "frostbite$.ti,ab." was replaced by "frostbit$.tw.". The 
second term "(metaanaly$ or (meta and analy$) or ((review or search$) and (systemat$))).ti,ab." was deleted. The amended strategy did not affect 
the search results. However, as an article may be published in the future and missed by not truncating the first term at the appropriate spot, the 
term "frostbit$.tw." should be used. The second term is superfluous.
Table 2: Search strategy applied in MEDLINE (Continued)
Table 3: Overview of study status, publication status, and sponsorship (Status: December 2006)
Study status
Completed (trials/
patients)
Discontinued (trials/
patients)
Ongoing (trials/
patients)
Unclear (trials/
patients)
Total (trials/patients)
Publication status
Published* 9/473 1/22 (2/88) (0/0) 10/495†
Unpublished‡ 4/328 5/826 (4/500) (3/?) 9/1154†
Sponsorship
Industrial 8/413 6/848 5/1076 0/0 19/2337
Unclear 5/388 0/0 1/30 3/? 9/418
Total 13/801 6/848 6/1106 3/? 28/2755
* Analysed patients.
† Published/unpublished: full-text publications of final results (completed trials) or interim results (discontinued trials) were available/not available.
‡ Planned patients.B
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Table 4: Search results for randomised controlled trials on negative pressure wound therapy* (Status: December 2006)
Study status No. Abstract Information source 
for abstract
Sponsor (ID†) Reply to inquiry to 
sponsor or author
Patients 
planned‡
Patients ana-
lysed§
Results data 
available
Full-text publica-
tion available||
Completed
1 Vuerstaek 
[74]
WUWHS 2004 KCI (VAC VLU) KCI - 60 Yes¶ Vuerstaek 2006 [23]
2 No abstract - Unclear - - 60 Yes¶ Llanos 2006 [25]
3 Obdeijn [75] WUWHS 2004 KCI (No ID) KCI - 65 Yes¶ Braakenburg 2006 
[21]
4 Payne [76] WUWHS 2004 KCI (VAC 2001–
07)
KCI; author - 162 Yes# Armstrong 2005 [22]
5 Moues [77] WUWHS 2004 KCI (PMID 
14974959)
KCI - 54 Yes# Moues 2004 [20]
6 Heath [78] The Cochrane Library KCI (PMID 
15468399)
KCI; author - 20 Yes# Moisidis 2004 [18]
7 No abstract - KCI (PMID 
14534844)
KCI - 6 Yes# Eginton 2003 [17]
8 No abstract - KCI (PMID 
12625392)
KCI - 22 Yes# Wanner 2003 [24]
9 Joseph [79] The Cochrane Library KCI (No ID) KCI - 24 Yes# Joseph 2000 [19]
10 Adams [26] NRR Unclear No reply Unclear Unclear No No
11 Fryer [27] ClinicalTrials.gov Unclear No reply 120 Unclear No No
12 McCarthy 
[28]
NRR Unclear Author ** 160 Unclear No No
13 Walker [29] NRR Unclear No reply 48 Unclear No No
Subtotal 13 328 473
Discontinued
14 No abstract - KCI (PMID 
12142596)
KCI - 22 Yes# Interim results: Ford 
2002 [30]
15 No abstract KCI KCI (VAC 2001–
02)
KCI 214 - No No
16 Bayer [31] WUWHS 2004 KCI (VAC 2002–
09)
KCI 116 - No No
17 Greer [33] The Cochrane Library KCI (No ID) KCI †† 80 - No No
18 Orgill [34] WUWHS 2004 KCI (VAC 2002–
10)
KCI 116 - No No
19 Stannard [35] WUWHS 2004 KCI (VAC 2001–
06)
KCI; author 300 - No NoB
M
C
 
M
e
d
i
c
a
l
 
R
e
s
e
a
r
c
h
 
M
e
t
h
o
d
o
l
o
g
y
 
2
0
0
8
,
 
8
:
4
h
t
t
p
:
/
/
w
w
w
.
b
i
o
m
e
d
c
e
n
t
r
a
l
.
c
o
m
/
1
4
7
1
-
2
2
8
8
/
8
/
4
P
a
g
e
 
7
 
o
f
 
1
6
(
p
a
g
e
 
n
u
m
b
e
r
 
n
o
t
 
f
o
r
 
c
i
t
a
t
i
o
n
 
p
u
r
p
o
s
e
s
)
Subtotal 6 826 22
Ongoing
20 Armstrong 
[36]
WUWHS 2004 KCI (VAC 2001–
08)
KCI; author 206 - - No
21 McCarthy 
[37]
ClinicalTrials.gov Unclear No reply 30 - - No
22 Molnar [38] WUWHS 2004 KCI (VAC 2001–
00)
KCI 50 - - No
23 Niezgoda [39] WUWHS 2004 KCI (VAC 2001–
01)
KCI 214 - - No
24 Stannard [40] WUWHS 2004 KCI (VAC 2001–
04)
KCI; author 258 (44) Yes¶ Interim results: 
Stannard 2006 [80]
25 Stannard [41] WUWHS 2004 KCI (VAC 2001–
05)
KCI; author 348 (44) Yes¶ Interim results: 
Stannard 2006 [80]
Subtotal 6 1106 (88)
Unclear
26 Foo [42] WUWHS 2004 Unclear No reply Unclear - No No
27 Gupta [43] WHS 2001 Unclear No reply Unclear - No No
28 Lantis [44] WUWHS 2004 Unclear No reply Unclear - No No
Subtotal 3 Unclear
Total (all 
trials)
28 2260 495
* Not classified by IQWiG as an RCT on NPWT (in contrast to other systematic reviews): McCallon 2000 [69]; Genecov 1998 [70]; Buttenschoen 2001 [81]; Jeschke 2004 [82].
† The PubMed ID number, when available, is used by KCI as the study ID for published RCTs.
‡ Number of patients planned in unpublished and ongoing studies as stated in abstracts and personal communications.
§ Number of patients analysed in published studies.
|| Full-text publication of interim or final results (any study status).
¶ Results considered in the IQWiG rapid report.
# Results considered in the IQWiG systematic review.
** The author replied to IQWiG's first request for information and stated that the trial was ongoing. However, according to information provided by the NRR (accessed on 04 Feb 2007), this trial has 
since been completed. A second query was not answered.
†† According to KCI, 16 patients were enrolled in this trial.
ID: Identification code; NRR: National Research Register; PMID: PubMed Identification Code; VLU: venous leg ulcer; WHS: Wound Healing Society; WUWHS: World Union of Wound Healing 
Societies.
Table 4: Search results for randomised controlled trials on negative pressure wound therapy* (Status: December 2006) (Continued)BMC Medical Research Methodology 2008, 8:4 http://www.biomedcentral.com/1471-2288/8/4
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Flow chart of the literature search for RCTs Figure 1
Flow chart of the literature search for RCTs.
Search in bibliographic databases in 
May 2005
MEDLINE (N=1138)
EMBASE (N=942)
CINAHL (N=129)
The Cochrane Library (N=303)
Total citations: N=2512
Inclusion:  Citations provided in 29 expert 
statements to the German Federal Joint 
Committee N=851
Exclusion: Duplicates N=959
Citations excluding duplicates: N=2675
Citations including duplicates N=3634
Exclusion: Not relevant N=2323
Potentially relevant citations N=317
RCTs N=28
(including conference abstracts and 
unpublished study information)
Exclusion: Systematic reviews N=10
Inclusion: Additional citations from 
congress reports, study registries, 
systematic reviews, manufacturers, and 
authors N=20
Exclusion: No RCT N=279
Inclusion: Citations retrieved from 
bibliographic databases in the search 
update (December 2006) N=251
RCTs N=12 (11 full-text publications)BMC Medical Research Methodology 2008, 8:4 http://www.biomedcentral.com/1471-2288/8/4
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RCTs (1106 patients; 40%) were ongoing [36-41], and the
status of 3 RCTs was unclear [42-44] (Table 3). According
to KCI, the main reasons for discontinuation were slow
enrolment, high attrition rates, changes in clinical prac-
tice, or design flaws [6].
Full-text publications were available on 30% of the 1649
patients in the 19 completed or discontinued RCTs (495
analysed patients in 10 published RCTs vs. 1154 planned
patients in 9 unpublished RCTs). Of the 14 conference
abstracts on these 19 trials, 6 abstracts (43%) were later
published as full-text articles.
Table 5: Sources of conference abstracts and unpublished study information on 28 RCTs: databases, trial registers, and systematic 
reviews
No Abstracts or 
other 
sources
Bibliographic databases Trial registers Systematic reviews
MEDLINE, 
EMBASE or 
CINAHL
Cochrane 
Clinical 
Trials
CT.gov NRR Evans 
2001 [83]
Samson 
2004 [9]
Pham 
2006 [68]
Fisher 2003 [84]; 
Higgins 2003 [85]; 
Costa 2005 [67]; 
OHTAC 2006 [10]
1 Vuerstaek [74] - + - - - + - -
2 No abstract* - - - - - - - -
3 Obdeijn [75] - + - - - + - -
4 Payne [76] - + - - - + - -
5 Moues [77] - + - - - + - -
6 Heath [78] - + - - + - + -
7N o  a b s t r a c t † -- - - - - - -
8N o  a b s t r a c t ‡ -- - - - - - -
9 Joseph [79] - + - - - - - -
10 Adams [26] - - - + - - + -
11 Fryer [27] - - + - - - + -
12 McCarthy [28] - - - + - - + -
13 Walker [29] - - - + - - + -
14 No abstract§ -- - - - - - -
15 No abstract|| -- - - - + - -
16 Bayer [31] - + - - - + - -
17 Greer [33] - + - - + - + -
18 Orgill [34] - + - - - + - -
19 Stannard [35] - + - - - + - -
20 Armstrong 
[36]
-+ - - - + - -
21 McCarthy [37] - - + - - - - -
22 Molnar [38] - + - - - + - -
23 Niezgoda [39] - + - - - + - -
24 Stannard [40] - + - - - + - -
25 Stannard [41] - + - - - + - -
26 Foo [42] - + - - - + - -
27 Gupta [43] - + - - - - - -
28 Lantis [44] - + - - - + - -
01 8 2 3 2 1 5 6 0
* No preceding abstract was identified concerning the full-text article by Llanos 2006 (Tables 7–9).
† No preceding abstract was identified, but information by the manufacturer KCI was provided concerning the full-text article by Eginton 2003 
(Tables 7–9).
‡ No preceding abstract was identified, but information by the manufacturer KCI was provided concerning the full-text article by Wanner 2003 
(Tables 7–9).
§No preceding abstract was identified, but information by the manufacturer KCI was provided concerning the full-text article by Ford 2002 (Tables 
7–9).
|| No preceding abstract was identified, but information by the manufacturer KCI was provided concerning this discontinued study KCI ID VAC 
2001–02.
CT.gov: ClinicalTrials.gov (United States); NRR: National Research Register (United Kingdom National Health System); RCT: randomised 
controlled trialBMC Medical Research Methodology 2008, 8:4 http://www.biomedcentral.com/1471-2288/8/4
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Response behaviour of manufacturers and authors
A total of 17 authors and 2 manufacturers were contacted,
of whom 10 (59%) and 2 (100%) responded respectively.
KCI readily provided information on study and publica-
tion status and on methodological issues. BSM did not
sponsor relevant RCTs and provided information only on
case reports.
One author provided information on an RCT that had
been classified as "ongoing", and stated that this trial had
recently been completed and the manuscript submitted to
The Lancet [22]. As this trial included 162 analysed
patients and was the largest RCT on NPWT conducted so
far, IQWiG postponed the publication of its review by 2
months until the final results of this RCT were available,
in order to include the results in the body of evidence.
Table 6: Sources of conference abstracts and unpublished study information on 28 RCTs: manufacturers, authors, congress 
proceedings, and authorities
No Abstracts or 
other sources
Manufacturers Authors* Congress proceedings* Authorities*
Kinetic Concepts, 
Inc.
Blue Sky Medical WUWHS 2004 
[45]
Others Experts 2003† Others
1 Vuerstaek [74] + - - + - - -
2N o  a b s t r a c t ‡ - - - - ---
3 Obdeijn [75] + - - + - + -
4 Payne [76] + - + + - - -
5 Moues [77] + - - + - + -
6 Heath [78] + - + - - - -
7N o  a b s t r a c t § + - - - ---
8N o  a b s t r a c t || + - - - ---
9 Joseph [79] + - - - - + -
10 Adams [26] - - - - - - -
11 Fryer [27] - - - - - - -
12 McCarthy [28] - - + - - - -
13 Walker [29] - - - - - - -
14 No abstract¶ + - - - ---
15 No abstract# + - - - ---
1 6 B a y e r  [ 3 1 ] + - - + ---
17 Greer [33] + - - - - + -
18 Orgill [34] + - - + - - -
19 Stannard [35] + - - + - - -
20 Armstrong [36] + - + + - - -
21 McCarthy [37] - - - - - - -
22 Molnar [38] + - - + - - -
23 Niezgoda [39] + - - + + - -
24 Stannard [40] + - - + - - -
25 Stannard [41] + - - + - - -
26 Foo [42] - - - + - - -
27 Gupta [43] - - - - + - -
28 Lantis [44] - - - + - + -
19 0 4 14 2 5 0
* See Table 1.
† Citations submitted by experts to the German Federal Joint Committee.
‡ No preceding abstract was identified concerning the full-text article by Llanos 2006 (Tables 7–9).
§No preceding abstract was identified, but information by the manufacturer KCI was provided concerning the full-text article by Eginton 2003 
(Tables 7–9).
|| No preceding abstract was identified, but information by the manufacturer KCI was provided concerning the full-text article by Wanner 2003 
(Tables 7–9).
¶No preceding abstract was identified, but information by the manufacturer KCI was provided concerning the full-text article by Ford 2002 (Tables 
7–9).
# No preceding abstract was identified, but information by the manufacturer KCI was provided concerning this discontinued study KCI ID VAC 
2001–02.
RCT: randomised controlled trial; WUWHS: World Union of Wound Healing SocietiesBMC Medical Research Methodology 2008, 8:4 http://www.biomedcentral.com/1471-2288/8/4
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Literature sources
The sources of the conference abstracts and unpublished
study information referring to 28 RCTs on NPWT are
shown in Tables 5, 6: most information was obtained
from KCI (19), followed by Cochrane (18), a systematic
review (15) [9], and congress proceedings (14) [45].
The sources of all 11 published full-text articles (referring
to 12 completed, discontinued or ongoing RCTs) are
shown in Tables 7, 8, 9. All 11 articles were obtained from
the Cochrane Library followed by KCI (10), MEDLINE
(10), and EMBASE (9).
Table 7: Sources of 11 published full-text articles on 12 RCTs: databases and trial registers
No Full-text articles Bibliographic databases Trial registers
MEDLINE EMBASE Cochrane Clinical Trials CINAHL CT.gov NRR
1 Braakenburg 2006 [21] + + + - - -
2 Stannard 2006 [80]* + + + - - -
3 Vuerstaek 2006 [23] + - + - + -
4 Llanos 2006 [25] + + + - - -
5 Armstrong 2005 [22] + + + + + -
6 Moisidis 2004 [18] + + + - - -
7 Moues 2004 [20] + + + + - -
8 Eginton 2003 [17] + + + - - -
9 Wanner 2003 [24] + + + - - -
10 Ford 2002 [30] + + + - - -
11 Joseph 2000 [19] - - + + - -
10 9 11 3 2 0
* Stannard 2006 [80]: one article presenting preliminary results of 2 ongoing RCTs [40,41].
CT.gov: ClinicalTrials.gov (United States); NRR: National Research Register (United Kingdom National Health System); RCT: randomised 
controlled trial
Table 8: Sources of 11 published full-text articles on 12 RCTs: systematic reviews
No Full-text 
articles
Systematic reviews
Evans 2001 
[83]
Fisher 2003 
[84]
Higgins 2003 
[85]
Samson 2004 
[9]
Costa 2005 
[67]
Pham 2006 
[68]
OHTAC 2006 
[10]
1 Braakenburg 
2006 [21]
-- - --- -
2 Stannard 2006 
[80]*
-- - --- -
3 Vuerstaek 2006 
[23]
-- - --- -
4 Llanos 2006 [25] - - - - - - -
5 Armstrong 2005 
[22]
-- - ---+
6 Moisidis 2004 
[18]
-- - -+ ++
7 Moues 2004 [20] - - - + + + +
8 Eginton 2003 
[17]
-- -++ +-
9 Wanner 2003 
[24]
--+++ ++
10 Ford 2002 [30] - + + + + + +
11 Joseph 2000 [19] + + + + + + +
12 3 566 6
* Stannard 2006 [80]: one article presenting preliminary results of 2 ongoing RCTs [40,41].
RCT: randomised controlled trialBMC Medical Research Methodology 2008, 8:4 http://www.biomedcentral.com/1471-2288/8/4
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Summary of quality assessment and outcomes
Published trials
The overall methodological quality of the 12 published
RCTs included in the IQWiG systematic review and rapid
report was poor. Methodological flaws included the lack
of blinding, the lack of intention-to-treat analyses, inade-
quate allocation concealment, the unclear definition of
primary outcomes, and high drop-out rates. Significant
differences in favour of NPWT for wound healing param-
eters, such as time to wound closure or the incidence of
wound closure, were shown in 3 of 7 RCTs analysing these
outcomes. Data on other patient-relevant outcomes, such
as reoperation rates or pain scores, were scarce or not
interpretable.
Unpublished trials
Because of insufficient available information on the 9
completed or discontinued unpublished RCTs, an assess-
ment of their quality could not be conducted. Regarding
the 5 discontinued industry-sponsored trials, as stated, the
reasons for discontinuation were provided by KCI, which
also reported the number of enrolled patients for one trial
[33]. However, there was no response to a further request
from IQWIG asking for more detailed information on all
discontinued trials, such as the number of enrolled
patients and other results data. Regarding the 4 completed
RCTs with unclear sponsorship, the authors of publica-
tions did not respond to IQWiG's request to provide
results data (Table 4). Consequently, the results of unpub-
lished RCTs could not be considered in the review.
Industrial sponsorship
The manufacturer KCI sponsored the majority (19/28) of
RCTs (68% of trials referring to 85% of patients planned
or analysed). The sponsorship of the remaining trials was
unclear.
Discussion
The main objective of this paper was to identify unpub-
lished RCTs on NPWT within the framework of a system-
atic review. An RCT was classified as "unpublished" if no
full-text paper on final study results (completed trials) or
interim results (discontinued trials) was available.
An extensive search strategy was employed that included
handsearching of retrievals, as well as contacting manu-
facturers and authors of publications. The sensitivity of
bibliographic database searching for RCTs is reported to
be unsatisfactory [46], and multi-source searching has
been recommended to retrieve all available RCTs [47]. In
this context, the usefulness of handsearching and contact-
ing experts has been demonstrated [48,49]. The extensive
search strategy was also useful to detect ongoing RCTs, of
which one [22] was subsequently added to the evidence
base.
A total of 28 RCTs referring to at least 2755 patients were
identified. The publications on completed or discontin-
ued RCTs reported data on less than a third of patients
planned or analysed. Less than half of the conference
abstracts on these trials were later published as full-text
publications; similar results were found in a review by
Scherer et al, who found a full-text publication rate for
Table 9: Sources of 11 published full-text articles on 12 RCTs: manufacturers, authors, congress proceedings, and authorities
Manufacturers Authors* Congress 
proceedings*
Authorities*
No Full-text articles Kinetic Concepts, 
Inc.
Blue Sky Medical Experts 2003† Others
1 Braakenburg 2006 [21] + - - - - -
2 Stannard 2006 [80]‡ +- - - - -
3 Vuerstaek 2006 [23] + - - - - -
4 Llanos 2006 [25] - - - - - -
5 Armstrong 2005 [22] + - - - - -
6 Moisidis 2004 [18] + - - - - -
7 Moues 2004 [20] + - - - - -
8 Eginton 2003 [17] + - - - + -
9 Wanner 2003 [24] + - - - + -
10 Ford 2002 [30] + - - - + -
11 Joseph 2000 [19] + - - - + -
10 0 0 0 4 0
* See Table 1.
† Citations submitted by experts to the German Federal Joint Committee.
‡ Stannard 2006 [80]: one article presenting preliminary results of 2 ongoing RCTs [40,41].
RCT: randomised controlled trialBMC Medical Research Methodology 2008, 8:4 http://www.biomedcentral.com/1471-2288/8/4
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abstracts describing RCTs or controlled clinical trials of
about 60% [50].
On the basis of results of published data alone, the IQWiG
review and rapid report concluded that although there
was some indication that NPWT may improve wound
healing, the body of evidence available was insufficient to
clearly prove an additional clinical benefit of NPWT. This
finding is in line with findings from previous reviews.
Regarding the discontinued unpublished trials, according
to the manufacturer the main reason for discontinuation
was insufficient patient numbers. No results data for these
trials were available. Regarding the completed unpub-
lished trials, the authors of conference abstracts did not
respond to IQWiG's request for information. Therefore,
unpublished results data could not be considered in the
IQWiG review and consequently the impact of unpub-
lished data on the conclusions of reviews based on pub-
lished data could not be assessed.
Publication bias caused by unpublished data
Previous research has shown that inclusion of unpub-
lished data in systematic reviews may affect the review's
prior conclusions [12,13]. The most prominent example
in recent years has been the evidence on serotonin
reuptake inhibitors (SSRIs) in paediatric depression: a sys-
tematic review of published versus unpublished data
showed that whereas published trials indicated a favoura-
ble risk-benefit profile, the addition of unpublished data
reversed this profile for some SSRIs [11].
Klassen 2002 assessed the proportion of RCTs presented
at a major paediatric meeting that were subsequently pub-
lished as full publications; about 60% of abstracts were
subsequently published, and RCTs were more likely to be
published if they favoured the new therapy. The author
concluded that "publication bias is a serious threat to
assessing the effectiveness of interventions in child
health" and called for a registry of RCTs in children so that
the totality of evidence could be assessed [51].
As unpublished results data on NPWT were not available,
no statement can be made on the impact of unpublished
data on the validity of published evidence. However, if
one assumes a "worst case scenario" (all unpublished tri-
als show results in favour of conventional therapy), the
current conclusion would no longer hold that there is
some indication of a potential advantage of NPWT over
conventional therapy.
Besides possible problems of statistical evaluation due to
insufficient sample sizes, the reasons for the existence of
unpublished RCTs on NPWT remain unclear and one can
only speculate. For example, it may be possible that some
of these RCTs remained unpublished because they were of
poor quality or produced negative results. Previous
research has shown that studies with statistically signifi-
cant or positive results are more likely to be published
than those with non-significant or negative results, and
are also published earlier [52-54]. These studies also lead
to a greater number of publications, and are more likely to
be published in high impact factor journals [55]. As for
discontinued trials, even if small sample sizes make statis-
tical evaluation difficult, in our opinion the full datasets
of such trials should be publicly accessible to ensure that
the evidence base is complete.
The inclusion of unpublished data in systematic reviews is
controversial. Although less than a third of meta-analyses
include unpublished data, nearly 80% of meta-analysts
and methodologists believe that unpublished data should
definitely or probably be included in systematic reviews;
in contrast, less than half of journal editors agree [56]. The
identification of unpublished data has been recom-
mended to minimise the risk of bias in systematic reviews
[12], but there are variations in policy regarding their
inclusion [57]. This may be explained by incomplete or
inaccurate reporting and the subsequent difficulties in
assessing the methodological quality of trials [57,58].
In general, the quality of reporting of systematic reviews
on both drug and non-drug interventions is inconsistent
[59]. Moreover, systematic reviews on non-drug interven-
tions (e.g. surgical techniques) face specific problems,
such as the limited quality and quantity of RCTs [60].
Searching for unpublished data and conducting sensitiv-
ity analyses to assess their impact is recommended for
topics with little evidence and new or evolving interven-
tions [58]. In their commentary on the problem of con-
ducting systematic reviews of new health technologies,
Moher and Schachter concluded that the inclusion of
unpublished data was of "paramount importance" in
assessing the usefulness of an intervention [61].
The role of industrial sponsorship
Approximately two thirds of the RCTs on NPWT were
sponsored by one manufacturer (KCI). Industrial spon-
sorship of clinical trials is common. The percentage of
industry-sponsored clinical trials has increased to over
60% in recent years and the number of industry employ-
ees named as co-authors of clinical trial publications is ris-
ing [62]. However, the role of industrial sponsorship in
clinical research is controversial. Industry sponsorship is
discussed as being associated with the following factors:
selection of inappropriate comparators, selective report-
ing of more favourable per protocol analyses, pro-indus-
try conclusions, as well as restrictions on publication and
data sharing [63-65]. A comparison of Cochrane reviews
versus industry-supported meta-analyses showed that theBMC Medical Research Methodology 2008, 8:4 http://www.biomedcentral.com/1471-2288/8/4
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latter came to more favourable conclusions on the same
drugs [66]. The available data on NPWT are insufficient to
make definite conclusions about the impact of industrial
sponsorship in this field.
Differences in primary study selection
Five systematic reviews on NPWT (including the IQWiG
review) published in December 2004 or later showed con-
siderable differences in the selection of primary studies
published between 1994 and 2004 [6,9,10,67,68]. There
was agreement between reviews regarding the selection of
4 RCTs [19,20,24,30]. One further study [17] classified by
IQWiG as an eligible RCT was not classified accordingly
(or identified) by 2 other reviews [10,67]. A study [69]
classified as an eligible RCT by 2 reviews [9,68] was classi-
fied as non-randomised by IQWiG, and one study [70]
classified as an eligible RCT by one other review [68] was
also classified as non-randomised by IQWiG. These find-
ings indicate that in systematic reviews on NPWT, search
strategies, inclusion criteria, and classification of primary
studies are not applied in a standardised manner.
Conclusion
Multi-source comprehensive searches identify unpub-
lished clinical trial data. However, lack of access to unpub-
lished study results data raises doubts about the
completeness of the evidence base on NPWT. The imple-
mentation of regulations such as prospective mandatory
trial registration and the obligation to publish all results is
needed to ensure that independent researchers have access
to all outcomes of completed or discontinued clinical tri-
als.
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